+

WO1998022554A1 - A biocidal corrosion inhibiting composition - Google Patents

A biocidal corrosion inhibiting composition Download PDF

Info

Publication number
WO1998022554A1
WO1998022554A1 PCT/AU1997/000784 AU9700784W WO9822554A1 WO 1998022554 A1 WO1998022554 A1 WO 1998022554A1 AU 9700784 W AU9700784 W AU 9700784W WO 9822554 A1 WO9822554 A1 WO 9822554A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
composition according
corrosion inhibiting
inhibiting composition
biocidal
Prior art date
Application number
PCT/AU1997/000784
Other languages
French (fr)
Inventor
Bruce Phillip Green
Original Assignee
Health And Hygiene International Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health And Hygiene International Pty. Ltd. filed Critical Health And Hygiene International Pty. Ltd.
Priority to EP97945666A priority Critical patent/EP1009781A4/en
Priority to AU51105/98A priority patent/AU5110598A/en
Publication of WO1998022554A1 publication Critical patent/WO1998022554A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23F—NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25
    • C23F11/00—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent
    • C23F11/08—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent in other liquids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/02—Anti-oxidant compositions; Compositions inhibiting chemical change containing inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/30—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing heterocyclic ring with at least one nitrogen atom as ring member

Definitions

  • This invention relates to a corrosion inhibiting composition, and in particLilar, to a corrosion inhibiting composition for use with a strong oxidising agent.
  • the invention is particularly applicable for sterilising medical instruments which may include brass, copper, aluminium, stainless steel, carbon steel and plastic parts.
  • strong oxidising solutions can catise corrosion in a variety of metals. This is of particular concern in the medical field where strong oxidising solutions are used to sterilise medical equipment.
  • the equipment is, for example, immersed in a bath of oxidising solution, such as an aq ieous solution of stabilised hydrogen peroxide, activated glutaraldehyde, chlorine dioxide or chlorine solution.
  • the solution can cause surface or local corrosion of metal parts of the medical instruments.
  • the present invention provides a corrosion inhibiting composition for use in combination with a strong oxidising agent, said composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt.
  • the preferred aromatic triazoles are benzotriazole and tolyltriazole, benzotriazole being more preferred.
  • the preferred molybdate salts are alkali metal salts such as sodium molybdate.
  • the preferred nitrate salts are alkali metal salts such as sodium nitrate.
  • the corrosion inhibiting composition may include a free-flow agent such as silicon dioxide.
  • Silicon dioxide is suitable as it is inert in oxidising solutions. Fumed silicon dioxide improves flow properties of the composition when the composition is in powder form and also gives improved dispersion and solubilisation of the powder in water. It is theorised that this is d ie to an alteration in electrostatic charge and prevention of attractive forces thus inhibiting clumping.
  • the particle surface change from hydrophobic to hydrophilic allows rapid penetration of water through the powder thereby improving solubility.
  • the present invention provides a biocidal composition comprising a strong oxidising agent and a corrosion inhibiting composition, said corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt.
  • the corrosion inhibiting composition may be present in an amount of 1.5 - 15% by weight based on the total weight of the biocidal composition, preferably including 0.5 - 5% by weight of each of the aromatic triazole, the molybdate salt and the nitrate salt.
  • the strong oxidising agent may be selected from the gimip consisting of monopersulphates, persulphates, perborates, hydrogen peroxide/ peracetic acid, benzoyl peroxide, permanganates, nitrates, and chlorous/hypochlorous acid.
  • Preferred oxidising agents are monopersulfates.
  • the oxidising agent may be included in an amount of 40 - 95% by weight, based on the total weight of the biocidal composition.
  • the biocidal composition may also include at least one water-soluble acid, the acid being selected for compatibility with the oxidising agent to maintain the appropriate pH.
  • the acid is preferably selected from the group consisting of malic acid, sulfamic acid, citric acid, lactic acid, sorbic acid, benzoic acid, salicylic acid, boric acid, glycolic acid and mixtures thereof. Most preferably, the acids are a mixture of malic acid, sulfamic acid and citric acid.
  • the biocidal composition may also include surfactants and free flow agents.
  • a preferred biocidal composition comprises:
  • the water-soluble acid is preferably a mixture of malic acid, sulfamic acid and citric acid.
  • Citric acid in particular, when solubilised with monopotassium persulphate provides excellent chelating properties and increases the permeability of the outer membrane of bacteria, particularly gram-negative bacteria. The acid accelerates the formation of nascent oxygen and boosts the reactivity of the oxygen with the cell's metabolism. It promotes the increase in speed of the metabolism to the detriment of the cell.
  • citric acid and the oxidising agent at the % aids the direct reaction of the molecular structure of the cell's proteins and interferes with enzyme reactions.
  • the nonionic surfactant may be selected from disulfonated anion surfactants, such as, DOWFAX 20B102 or alkyl polyether alcohol surfactants, such as, Triton DF16.
  • the sensitivity of the made up solution to trace metals and organic matter is also reduced, thus improving the Liseable life of the solution.
  • the composition preferably also includes 0.1 - 5% of a free flow agent such as fumed silicon dioxide.
  • the biocidal composition is usually made up in powder form and is diluted in deionised water for use, preferably to a concentration of 2.5-7.5% w/v more preferably 5% w/v.
  • the pH of the made up solution is approximately 2.0.
  • the present invention provides a method of reducing corrosivity of a strong oxidising agent characterised in that a strong oxidising agent is used in conjunction with a corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt.
  • the corrosion inhibiting composition comprises benzotriazole, an alkali metal molybdate salt such as sodium molybdate and an alkali metal nitrate salt such as sodmm nitrate.
  • the corrosion inhibiting composition may also include a free flow agent such as fumed silicon dioxide.
  • the present invention provides the use of the corrosion inhibiting composition of the first aspect of the invention for reducing the corrosivity of a strong oxidising agent.
  • the present invention provides a method of cleaning and sterilising a surface comprising contacting the surface with a strong oxidising agent and a corrosion inhibiting composition, said corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt.
  • the surface may be selected from plastics, carbon steel and metals including brass, aluminium, copper and alloys thereof and stainless steel.
  • the surface may comprise at least in part, one or more surfaces.
  • the surfaces will be at least partially protected from corrosion which may otherwise occur in the presence of the oxidising agent.
  • the surfaces are selected from metals.
  • Figure 1 is a graph of measured anodic current vs applied potential for a brass electrode for a 5% w/v solution of a composition of the present invention.
  • FigLire 2 is a graph of measured anodic current vs applied potential for a brass electrode for a 5% w/v solution of a reference composition used for comparative purposes.
  • Figure 3 is a graph of measured anodic current vs applied potential for an aluminium electrode comparing a 5% w/v solution of a composition of the present invention with a reference composition.
  • Figures 4 and 5 are graphs similar to Fig. 3 using an akiminium alloy electrode.
  • Figures 6 and 7 are graphs similar to Fig. 3 using stainless steel electrodes.
  • the test involves imposing on the test specimen a steadily increasing aggressive potential and observing the resulting anodic current. (This is a poteniodynamic procedure.) Until active corrosion (pitting) occurs, low anodic currents allow some comparison of the respective stabilities of metallic components and the likelihood of galvanic effects. The potential corresponding to the establishment of pitting is a measure of the effectiveness of the intrinsic passivity or of inhibition.
  • a single open cell which contains the test piece, suitably mounted as an electrode, a calomel reference electrode and an iridium counter electrode.
  • the potential between the test electrode and the reference is monitored and controlled by a Solartron Instruments Electrochemical Interface (Type 1286) which supplies the measured and recorded corrosion current via the Iridium electrode.
  • This instrument is computer controlled, either by a Hewlett Packard 9000/216 with Solartron software 1090 or an IBM PS2 system 80 with University written software for data logging, electrochemical control and graphic outputs.
  • Test electrodes are immersed in the electrolyte until the open circuit potential stabilises. The potential is then swept anodically until passivation or inhibition breaks down. It is an important feature of the experiment that the applied potential should change slowly (typically 0.5 mV Sec '1 ) to allow the surface phases to respond.
  • the cell is held at 20°C.
  • the metals to be tested were immersed in the electrolyte solutions described below for 2 hour periods.
  • the electrolytes correspond to biocidal compositions.
  • a corrosion inhibiting composition according to the present invention shown below as (A)
  • B a comparative reference composition containing a corrosion inhibiting composition outside the scope of the present invention
  • Nonionic surfactant 7.5%
  • compositions (A) and (B):
  • compositions are diluted with deionised water to a concentration of 5% w/w to form the electrolytes and the corrosiveness of each solution was compared using the potentiodynamic test described above.
  • the electrolyte is aggressive towards brass and copper but harmless to stainless steel.
  • the electrolyte is aggressive towards brass and copper but harmless to stainless steel.
  • composition of the present invention (A) there is a dramatic improvement in the performance of brass, aluminium and aluminium alloy. Good corrosion inhibition is also foLind on the stainless steels.
  • the combination of sodium nitrate with sodium molybdate and benzotriazole has a synergistic effect giving improved performance and allowing active levels to be reduced.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)

Abstract

A corrosion inhibiting composition for use in combination with a strong oxidising agent is disclosed. The corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt. A method of cleaning and sterilising a surface by contacting the surface with a strong oxidising agent and a corrosion inhibiting composition is also disclosed.

Description

A BIOCIDAL CORROSION INHIBITING COMPOSITION
Technical Field
This invention relates to a corrosion inhibiting composition, and in particLilar, to a corrosion inhibiting composition for use with a strong oxidising agent. Background Art
The invention is particularly applicable for sterilising medical instruments which may include brass, copper, aluminium, stainless steel, carbon steel and plastic parts. As will be clear to a person skilled in the art, strong oxidising solutions can catise corrosion in a variety of metals. This is of particular concern in the medical field where strong oxidising solutions are used to sterilise medical equipment. The equipment is, for example, immersed in a bath of oxidising solution, such as an aq ieous solution of stabilised hydrogen peroxide, activated glutaraldehyde, chlorine dioxide or chlorine solution. The solution can cause surface or local corrosion of metal parts of the medical instruments.
Sterilisation is, of course, required however it is desirable to eliminate or at least reduce corrosion. Throughout this specification, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising" will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers. Disclosure of the Invention
In a first aspect the present invention provides a corrosion inhibiting composition for use in combination with a strong oxidising agent, said composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt. The preferred aromatic triazoles are benzotriazole and tolyltriazole, benzotriazole being more preferred. The preferred molybdate salts are alkali metal salts such as sodium molybdate. The preferred nitrate salts are alkali metal salts such as sodium nitrate.
The corrosion inhibiting composition may include a free-flow agent such as silicon dioxide. Silicon dioxide is suitable as it is inert in oxidising solutions. Fumed silicon dioxide improves flow properties of the composition when the composition is in powder form and also gives improved dispersion and solubilisation of the powder in water. It is theorised that this is d ie to an alteration in electrostatic charge and prevention of attractive forces thus inhibiting clumping. The particle surface change from hydrophobic to hydrophilic allows rapid penetration of water through the powder thereby improving solubility.
In a second aspect the present invention provides a biocidal composition comprising a strong oxidising agent and a corrosion inhibiting composition, said corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt. The corrosion inhibiting composition may be present in an amount of 1.5 - 15% by weight based on the total weight of the biocidal composition, preferably including 0.5 - 5% by weight of each of the aromatic triazole, the molybdate salt and the nitrate salt.
The strong oxidising agent may be selected from the gimip consisting of monopersulphates, persulphates, perborates, hydrogen peroxide/ peracetic acid, benzoyl peroxide, permanganates, nitrates, and chlorous/hypochlorous acid. Preferred oxidising agents are monopersulfates. The oxidising agent may be included in an amount of 40 - 95% by weight, based on the total weight of the biocidal composition. The biocidal composition may also include at least one water-soluble acid, the acid being selected for compatibility with the oxidising agent to maintain the appropriate pH.
In a composition containing monopersulphates such as potassium monopersulphate, the acid is preferably selected from the group consisting of malic acid, sulfamic acid, citric acid, lactic acid, sorbic acid, benzoic acid, salicylic acid, boric acid, glycolic acid and mixtures thereof. Most preferably, the acids are a mixture of malic acid, sulfamic acid and citric acid.
The biocidal composition may also include surfactants and free flow agents.
A preferred biocidal composition comprises:
(a) 40- 95% potassium monopersulfate (commercial grade);
(b) 1.5- 30% of at least one water-soluble acid selected from the groLip consisting of malic acid, sulfamic acid, citric acid, lactic acid, sorbic acid, benzoic acid, salicylic acid, boric acid and glycolic acid;
(c) 0.5- 10% nonionic surfactant; (d) 1.5-15% corrosion inhibiting composition comprising benzotriazole, sodium molybdate and sodium nitrate.
The water-soluble acid is preferably a mixture of malic acid, sulfamic acid and citric acid. Citric acid in particular, when solubilised with monopotassium persulphate provides excellent chelating properties and increases the permeability of the outer membrane of bacteria, particularly gram-negative bacteria. The acid accelerates the formation of nascent oxygen and boosts the reactivity of the oxygen with the cell's metabolism. It promotes the increase in speed of the metabolism to the detriment of the cell.
The combination of citric acid and the oxidising agent at the % stated aids the direct reaction of the molecular structure of the cell's proteins and interferes with enzyme reactions.
The nonionic surfactant may be selected from disulfonated anion surfactants, such as, DOWFAX 20B102 or alkyl polyether alcohol surfactants, such as, Triton DF16.
The sensitivity of the made up solution to trace metals and organic matter is also reduced, thus improving the Liseable life of the solution.
The composition preferably also includes 0.1 - 5% of a free flow agent such as fumed silicon dioxide.
The biocidal composition is usually made up in powder form and is diluted in deionised water for use, preferably to a concentration of 2.5-7.5% w/v more preferably 5% w/v. The pH of the made up solution is approximately 2.0. In a third aspect the present invention provides a method of reducing corrosivity of a strong oxidising agent characterised in that a strong oxidising agent is used in conjunction with a corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt. Preferably the corrosion inhibiting composition comprises benzotriazole, an alkali metal molybdate salt such as sodium molybdate and an alkali metal nitrate salt such as sodmm nitrate. The corrosion inhibiting composition may also include a free flow agent such as fumed silicon dioxide.
In a fourth aspect the present invention provides the use of the corrosion inhibiting composition of the first aspect of the invention for reducing the corrosivity of a strong oxidising agent. In a fifth aspect the present invention provides a method of cleaning and sterilising a surface comprising contacting the surface with a strong oxidising agent and a corrosion inhibiting composition, said corrosion inhibiting composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt.
The surface may be selected from plastics, carbon steel and metals including brass, aluminium, copper and alloys thereof and stainless steel. The surface may comprise at least in part, one or more surfaces. The surfaces will be at least partially protected from corrosion which may otherwise occur in the presence of the oxidising agent. Preferably the surfaces are selected from metals. Brief Description of the Drawings
Figure 1 is a graph of measured anodic current vs applied potential for a brass electrode for a 5% w/v solution of a composition of the present invention.
FigLire 2 is a graph of measured anodic current vs applied potential for a brass electrode for a 5% w/v solution of a reference composition used for comparative purposes.
Figure 3 is a graph of measured anodic current vs applied potential for an aluminium electrode comparing a 5% w/v solution of a composition of the present invention with a reference composition.
Figures 4 and 5 are graphs similar to Fig. 3 using an akiminium alloy electrode.
Figures 6 and 7 are graphs similar to Fig. 3 using stainless steel electrodes.
In order that the invention be more clearly understood, preferred forms thereof will now be described with reference to the following examples. Best Modes The most straightforward electrochemical procedure has been applied in conjunction with the microscope examination of materials before and after testing. When driven electrochemically to corrosion during testing, the mode of degradation observed was by pitting. Consequently, estimates of "corrosion current" are not meaningful because the CLirrent densities depend on the specific areas of electrochemical activity which are not readily measurable and, indeed are changing continually both in number and extent.
The test involves imposing on the test specimen a steadily increasing aggressive potential and observing the resulting anodic current. (This is a poteniodynamic procedure.) Until active corrosion (pitting) occurs, low anodic currents allow some comparison of the respective stabilities of metallic components and the likelihood of galvanic effects. The potential corresponding to the establishment of pitting is a measure of the effectiveness of the intrinsic passivity or of inhibition. In practice, a single open cell is used which contains the test piece, suitably mounted as an electrode, a calomel reference electrode and an iridium counter electrode. The potential between the test electrode and the reference is monitored and controlled by a Solartron Instruments Electrochemical Interface (Type 1286) which supplies the measured and recorded corrosion current via the Iridium electrode. This instrument is computer controlled, either by a Hewlett Packard 9000/216 with Solartron software 1090 or an IBM PS2 system 80 with University written software for data logging, electrochemical control and graphic outputs.
Test electrodes are immersed in the electrolyte until the open circuit potential stabilises. The potential is then swept anodically until passivation or inhibition breaks down. It is an important feature of the experiment that the applied potential should change slowly (typically 0.5 mV Sec'1) to allow the surface phases to respond.
In the present tests, the cell is held at 20°C. The metals to be tested were immersed in the electrolyte solutions described below for 2 hour periods.
The electrolytes correspond to biocidal compositions. A corrosion inhibiting composition according to the present invention (shown below as (A)) and a comparative reference composition (B), containing a corrosion inhibiting composition outside the scope of the present invention, were added to the biocidal composition. Biocidal composition: Qty w/w
Potassium monopersulfate (commercial grade) 82.5%
Citric acid (ANH) 9.0%
Malic acid 0.5%
Sulfamic acid (ANH) 0.5%
Nonionic surfactant 7.5%
The above biocidal composition is added to the following compositions, (A) and (B):
(A) Corrosion Inhibiting composition of the invention:
Figure imgf000008_0001
The resulting compositions are diluted with deionised water to a concentration of 5% w/w to form the electrolytes and the corrosiveness of each solution was compared using the potentiodynamic test described above.
The resvilts of the test were assessed with reference to Figures 1 to 7.
For the comparative composition (B), the electrolyte is aggressive towards brass and copper but harmless to stainless steel. In practical use, for an item comprising stainless steel as well as brass, there would be a risk of contamination of the stainless steel components with corrosion products from brass. This could lead to harmful galvanic effects.
For the composition of the present invention (A) there is a dramatic improvement in the performance of brass, aluminium and aluminium alloy. Good corrosion inhibition is also foLind on the stainless steels. The combination of sodium nitrate with sodium molybdate and benzotriazole has a synergistic effect giving improved performance and allowing active levels to be reduced.
When used in conjunction with a strong oxidising agent, the reduction of corrosion inhibitor levels allows more oxidising agent to be present thus boosting biocidal activity.
It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive.

Claims

I. A corrosion inhibiting composition for use in combination with a strong oxidising agent, said composition comprising at least one aromatic triazole, at least one molybdate salt and at least one nitrate salt.
2. A corrosion inhibiting composition according to claim 1 wherein the aromatic triazole is selected from benzotriazole and tolyltriazole.
3. A corrosion inhibiting composition according to claim 1 wherein the molybdate salts are alkali metal salts, preferably sodium molybdate.
4. A corrosion inhibiting composition according to claim 1 wherein the nitrate salts are selected from alkali metal salts, preferably sodium nitrate.
5. A corrosion inhibiting composition according to any of the preceding claims which additionally includes a free-flow agent.
6. A corrosion inhibiting composition according to claim 5 wherein the free-flow agent is silicon dioxide.
7. A corrosion inhibiting composition according to claim 6 wherein the silicon dioxide is fumed silicon dioxide.
8. A biocidal composition comprising a strong oxidising agent and a corrosion inhibiting composition according to any one of the preceding claims.
9. A biocidal composition according to claim 8 wherein the corrosion inhibiting composition is present in an amount of 1.5 to 15% by weight based on the total weight of the biocidal composition.
10. A biocidal composition according to claim 9 wherein the corrosion inhibiting composition includes 0.5 to 5% by weight of each of the aromatic triazole, the molybdate salt and the nitrate salt.
II. A biocidal composition according to any one of claims 8 to 10 wherein the strong oxidising agent is selected from the group consisting of monopersulphates, persulphates, perborates, hydrogen peroxide/peracetic acid, benzoyl peroxide, permanganates, nitrates, and chlorous/hypochlorous acids.
12. A biocidal composition according to any one of claims 9 to 11 wherein the oxidising agent is in an amount of 40 to 95% by weight, based on the total weight of the biocidal composition.
13. A biocidal composition according to any one of claims 9 to 12, which further comprises at least one water-soluble acid.
14. A biocidal composition according to claim 13 wherein the acid is selected from the group consisting of maleic acid, SLilfamic acid, citric acid, lactic acid, sorbic acid, benzoic acid, salicylic acid, boric acid, glycolic acid.
15. A biocidal composition according to any one of claims 8 to 14 which further includes surfactants and free flow agents.
16. A biocidal composition comprising :
(a) 40-95% potassium monopersulphate
(b) 1.5-30% of at least one water-soluble acid selected from the group consisting of malic acid, sulfamic acid, citric acid, lactic acid, sorbic acid, benzoic acid, salicylic acid, boric acid and glycolic acid;
(c) 0.5-10% nonionic surfactant;
(d) 1.5-15% corrosion inhibiting composition comprising benzotriazole, sodium molybdate and sodium nitrate.
17. A biocidal composition according to claim 16 wherein the water soluble acid is a mixture of malic, sulfamic and citric acid.
18. A biocidal composition according to claim 16 or 17 which further comprises 0.1 to 5% w/w of free flow agent, preferably silicon dioxide.
19. A biocidal composition according to any one of claims 16 to 18 where the concentration is 2.5 to 7-5 %w/v and wherein the pH is approximately 2.0.
20. A method of reducing corrosivity of a strong oxidising agent characterised in that a strong oxidising agent is used in conjunction with a corrosion inhibiting composition according to any one of claims 1 to 7.
21. Use of the corrosion inhibiting composition according to any one of claims 1 to 7 for reducing the corrosivity of a strong oxidising agent.
22. A method of cleaning and sterilising a surface comprising contacting the surface with a strong oxidising agent and a corrosion inhibiting composition according to any one of claims 1 to 7.
23. A method according to claim 22 wherein the surface may comprise at least in part, one or more metal surfaces.
PCT/AU1997/000784 1996-11-18 1997-11-18 A biocidal corrosion inhibiting composition WO1998022554A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97945666A EP1009781A4 (en) 1996-11-18 1997-11-18 A biocidal corrosion inhibiting composition
AU51105/98A AU5110598A (en) 1996-11-18 1997-11-18 A biocidal corrosion inhibiting composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO3710A AUPO371096A0 (en) 1996-11-18 1996-11-18 Corrosion inhibiting composition
AUPO3710 1996-11-18

Publications (1)

Publication Number Publication Date
WO1998022554A1 true WO1998022554A1 (en) 1998-05-28

Family

ID=3798021

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1997/000784 WO1998022554A1 (en) 1996-11-18 1997-11-18 A biocidal corrosion inhibiting composition

Country Status (3)

Country Link
EP (1) EP1009781A4 (en)
AU (1) AUPO371096A0 (en)
WO (1) WO1998022554A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001086023A3 (en) * 2000-05-05 2002-05-10 Henkel Kgaa Inhibition of pitting and crevice corrosion
WO2004043148A1 (en) * 2002-11-12 2004-05-27 Mattersmiths Holdings Limited Methods of treating substrates and compositions therefor
WO2005112631A3 (en) * 2004-05-21 2006-03-09 Fellows Adrian An antimicrobial construction
US7030071B2 (en) 2002-02-26 2006-04-18 The Regents Of The University Of California Solid-water detoxifying reagents for chemical and biological agents
WO2008107082A1 (en) * 2007-03-05 2008-09-12 Poligrat Gmbh Method for the thermochemical passivation of stainless steel
CN105297029A (en) * 2015-11-20 2016-02-03 中国海洋石油总公司 Crude oil decalcifying agent matched corrosion inhibitor and preparation method thereof
CN113830848A (en) * 2021-10-14 2021-12-24 西安热工研究院有限公司 A kind of closed circulating water system molybdate concentration control device and using method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728452A (en) * 1986-01-17 1988-03-01 Pony Industries, Inc. Metal corrosion inhibition in closed cooling systems
EP0357238A2 (en) * 1988-08-08 1990-03-07 Steris Corporation Anti-microbial composition
US5350563A (en) * 1986-02-06 1994-09-27 Steris Corporation Cold sterilant with extended active life
WO1995007323A1 (en) * 1993-09-10 1995-03-16 Evans Cooling Systems, Inc. Nonaqueous heat transfer fluid
JPH07157887A (en) * 1993-11-19 1995-06-20 Seiken Kagaku Kogyo Kk Anti-corrosive anti-freeze for aluminum engine
GB2292687A (en) * 1994-08-26 1996-03-06 Bruce Philip Green Corrosion inhibition of oxidant-based anti-microbial compositions
US5545343A (en) * 1991-10-17 1996-08-13 Solvay Interox Limited Peracid compositions for medical disinfection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420201D0 (en) * 1994-10-06 1994-11-23 Green Bruce P Cold sterilant solution

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728452A (en) * 1986-01-17 1988-03-01 Pony Industries, Inc. Metal corrosion inhibition in closed cooling systems
US5350563A (en) * 1986-02-06 1994-09-27 Steris Corporation Cold sterilant with extended active life
EP0357238A2 (en) * 1988-08-08 1990-03-07 Steris Corporation Anti-microbial composition
US5545343A (en) * 1991-10-17 1996-08-13 Solvay Interox Limited Peracid compositions for medical disinfection
WO1995007323A1 (en) * 1993-09-10 1995-03-16 Evans Cooling Systems, Inc. Nonaqueous heat transfer fluid
JPH07157887A (en) * 1993-11-19 1995-06-20 Seiken Kagaku Kogyo Kk Anti-corrosive anti-freeze for aluminum engine
GB2292687A (en) * 1994-08-26 1996-03-06 Bruce Philip Green Corrosion inhibition of oxidant-based anti-microbial compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1009781A4 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001086023A3 (en) * 2000-05-05 2002-05-10 Henkel Kgaa Inhibition of pitting and crevice corrosion
US7030071B2 (en) 2002-02-26 2006-04-18 The Regents Of The University Of California Solid-water detoxifying reagents for chemical and biological agents
WO2004043148A1 (en) * 2002-11-12 2004-05-27 Mattersmiths Holdings Limited Methods of treating substrates and compositions therefor
WO2005112631A3 (en) * 2004-05-21 2006-03-09 Fellows Adrian An antimicrobial construction
WO2005112647A3 (en) * 2004-05-21 2006-04-27 Fellows Adrian An antimicrobial composition
WO2008107082A1 (en) * 2007-03-05 2008-09-12 Poligrat Gmbh Method for the thermochemical passivation of stainless steel
US8430973B2 (en) 2007-03-05 2013-04-30 Poligrat Gmbh Method for the thermochemical passivation of stainless steel
CN105297029A (en) * 2015-11-20 2016-02-03 中国海洋石油总公司 Crude oil decalcifying agent matched corrosion inhibitor and preparation method thereof
CN113830848A (en) * 2021-10-14 2021-12-24 西安热工研究院有限公司 A kind of closed circulating water system molybdate concentration control device and using method

Also Published As

Publication number Publication date
EP1009781A4 (en) 2000-11-15
EP1009781A1 (en) 2000-06-21
AUPO371096A0 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
Decroly et al. Study of the deposition of cerium oxide by conversion on to aluminium alloys
Dobryszycki et al. On some organic inhibitors of zinc corrosion in alkaline media
Refaey et al. Inhibition of chloride localized corrosion of mild steel by PO43−, CrO42−, MoO42−, and NO2− anions
Shibli et al. Co-inhibition characteristics of sodium tungstate with potassium iodate on mild steel corrosion
CA2320482A1 (en) Electrolytic synthesis of peracetic acid and other oxidants
Hausler Practical experiences with linear polarization measurements
EP0462666A1 (en) Phenyl mercaptotetrazole/tolyltriazole and/or benzotriazole corrosion inhibiting compositions
WO1998022554A1 (en) A biocidal corrosion inhibiting composition
Bastidas et al. A comparative study of benzotriazole and 2‐amino‐5‐mercapto‐1, 3, 4‐thiadiazole as Copper corrosion inhibitors in acid media
Suleiman et al. The pitting of stainless steel under a rust membrane at very low potentials
AlFalah et al. Corrosion inhibition potential of new oxo-pyrimidine derivative on mild steel in acidic solution: Experimental and theoretical approaches
Lakshminarayanan et al. Cyclic voltammetric behavior of certain copper-azole systems using carbon paste electrodes
Diab et al. Corrosion Inhibition of Copper in Acidic Solution by using a Natural Product as Henna Extract (Lawsonia inermis L).
Önal et al. Corrosion inhibition of aluminium alloys by tolyltriazole in chloride solutions
Chebabe et al. Corrosion inhibition of bronze alloy B66 by 4-amino-3-methyl-1, 2, 4-triazole-5-thione in 3 per cent NaCl solution
Chieb et al. The Inhibitive Effect of 3-Methyl 4-Amino 1, 2, 4 Triazole on the Corrosion of Copper-Nickel 70-30 in NaCl 3% Solution
Elango et al. Study on polyaniline‐ZnO used as corrosion inhibitors of 57S aluminium in 2 M NaOH solution
Radhakrishnan et al. Influence of Pb++ ions on the dissolution and passivation of nickel and Ni–21Cr in acidic solutions
US20040011659A1 (en) Method for inhibiting corrosion of alloys employing electrochemistry
Abd El Aal Measurements of pitting corrosion currents of zinc in near neutral media
Ashour et al. Effects of sulfide ions on the integrity of the protective film of benzotriazole on alpha brass in salt water
Caldwell et al. Rate of solution of zinc and aluminum while cathodic
Meziane et al. Effect of molybdate ions as corrosion inhibitors of iron in neutral aqueous solutions
Sherif et al. Electrochemical behaviour of aluminium in 1M NaCl solution: Part 1: Open circuit potential measurements
JP5145916B2 (en) Electrolyte for polarographic diaphragm electrode and polarographic diaphragm electrode

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 1997945666

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWP Wipo information: published in national office

Ref document number: 1997945666

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997945666

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载